Humacyte Q1 EPS $(0.29) Misses $(0.23) Estimate, Exits Quarter With Cash & Equivalents Worth $115.5M
Humacyte Q1 EPS $(0.29) Misses $(0.23) Estimate, Exits Quarter With Cash & Equivalents Worth $115.5M
Humacyte第一季度每股收益美元（0.29美元）未達到預期（0.23美元），本季度退出，現金及等價物價值1.155億美元
Humacyte (NASDAQ:HUMA) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.22) by 31.82 percent. This is a 19.44 percent increase over losses of $(0.36) per share from the same period last year.
Humacyte（納斯達克股票代碼：HUMA）公佈的季度虧損爲每股0.29美元，比分析師普遍預期的0.22美元（0.22美元）低31.82個百分點。這比去年同期每股虧損0.36美元（0.36美元）增長了19.44％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。